Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Aug 1;37(4):296-303.
doi: 10.1097/QCO.0000000000001029. Epub 2024 Jun 7.

Postexposure prophylaxis for occupational exposure to selected pathogens for healthcare personnel

Alison Han  1 , David K Henderson  2
Affiliations
Review

Postexposure prophylaxis for occupational exposure to selected pathogens for healthcare personnel

Alison Han et al. Curr Opin Infect Dis. .

Abstract

Purpose of review: Timely postexposure prophylaxis is important after an occupational exposure. Here we review select organisms, exposure opportunities in the healthcare setting, and postexposure prophylaxis regimens.

Recent findings: Needlestick injuries pose a risk of exposure to bloodborne pathogens, such as HIV, Hepatitis B, and Hepatitis C. Risk mitigation strategies should be reexamined in light of newer vaccines and therapeutics. Increased vaccine hesitancy and vaccine denialisms may foster the re-emergence of some infections that have become extremely uncommon because of effective vaccines. With increasing occurrences of zoonotic infections and the ease of global spread as evidenced by COVID-19 and mpox, healthcare exposures must also consider risks related to emerging and re-emerging infectious diseases.

Summary: Early recognition and reporting of occupational exposures to pathogens with available postexposure prophylaxis is key to mitigating the risk of transmission. Providers should be able to evaluate the exposure and associated risks to provide prompt and appropriate postexposure prophylaxis.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Box 1
Box 1
no caption available
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Centers for Disease Control and Prevention. Meningococcal Disease: Infection Control in Healthcare Personnel: Epidemiology and Control of Selected Infections Transmitted Among Healthcare Personnel and Patients Atlanta, GA: U.S. Department of Health and Human Services; 2024 [updated November 2, 2022; cited 3/21/2024]. Available at: https://www.cdc.gov/infectioncontrol/guidelines/healthcare-personnel/sel....
    1. McNamara L, Blain, A. Manual for the Surveillance of Vaccine-Preventable Diseases: Chapter 8: Meningococcal Disease. Atlanta, GA: Centers for Disease Control and Prevention; 2024 [updated 1/5/2022. Available at: https://www.cdc.gov/vaccines/pubs/surv-manual/chpt08-mening.html.
    1. Berry I, Rubis AB, Howie RL, et al. . Selection of antibiotics as prophylaxis for close contacts of patients with meningococcal disease in areas with ciprofloxacin resistance – United States, 2024. MMWR Morb Mortal Wkly Rep 2024; 73:99–103. - PMC - PubMed

    2. An important notice about the presence of increasing ciprofloxacin resistance among meningococci in selected areas of the US.

    1. Food and Drug Administration. Penbraya Washington, DC: U.S. Department of Health and Human Services; 2024 [updated 11/27/2023; cited 4/2/2024]. Available at: https://www.fda.gov/vaccines-blood-biologics/vaccines/penbraya.
    1. Murthy N, Wodi AP, McNally VV, et al. . Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older – United States. MMWR Morb Mortal Wkly Rep 2024; 73:11–15. - PMC - PubMed

    2. The CDC's Advisory Committee on Immunization Practices’ recommendations for people 19 years of age or older that includes the first recommendation for the use of the pentavalent meningococcal vaccine.

MeSH terms